# Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.

> **NCT02713139** · PHASE3 · WITHDRAWN · sponsor: **Ache Laboratorios Farmaceuticos S.A.**

## Conditions studied

- Sexual Active Women
- Vaginal Discharge

## Interventions

- **DRUG:** Clotrimazole + Metronidazole
- **DRUG:** Metronidazole
- **DRUG:** Clotrimazole

## Key facts

- **NCT ID:** NCT02713139
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-09
- **Primary completion:** 2014-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to budget limitations, the company decided to withdraw this study.
- **Last updated:** 2016-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713139, "Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02713139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
